Lower risk of metabolic complications seen with darunavir vs. atazanavir plus ritonavir in HIV Dec. 24, 2010
FDA approves Prezista/ritonavir q.d. for treatment-experienced adults with HIV and no DRV RAMs Dec. 15, 2010